Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease
Clinical trial NCT00032799 · COMPLETED
Trial details
- NCT number
- NCT00032799
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-12-01
- Primary completion
- 2003-09-01
- Enrollment
- 905
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.